Halyard Health, Inc. (HYH) Position Lessened by Strs Ohio
Strs Ohio cut its holdings in Halyard Health, Inc. (NYSE:HYH) by 25.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,800 shares of the medical instruments supplier’s stock after selling 6,200 shares during the quarter. Strs Ohio’s holdings in Halyard Health were worth $801,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also bought and sold shares of the company. Renaissance Technologies LLC bought a new stake in Halyard Health during the 1st quarter valued at approximately $727,000. Malaga Cove Capital LLC boosted its position in Halyard Health by 1.0% during the 2nd quarter. Malaga Cove Capital LLC now owns 56,760 shares of the medical instruments supplier’s stock valued at $2,243,000 after acquiring an additional 568 shares in the last quarter. KCG Holdings Inc. bought a new stake in Halyard Health during the 1st quarter valued at approximately $369,000. Koch Industries Inc. bought a new stake in Halyard Health during the 2nd quarter valued at approximately $297,000. Finally, Schwab Charles Investment Management Inc. boosted its position in Halyard Health by 3.6% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 797,993 shares of the medical instruments supplier’s stock valued at $31,346,000 after acquiring an additional 27,421 shares in the last quarter. 91.08% of the stock is currently owned by institutional investors.
Several research firms have recently issued reports on HYH. ValuEngine upgraded shares of Halyard Health from a “hold” rating to a “buy” rating in a report on Saturday. Stifel Nicolaus reiterated a “buy” rating and set a $52.00 target price on shares of Halyard Health in a report on Friday. Zacks Investment Research lowered shares of Halyard Health from a “buy” rating to a “sell” rating in a report on Wednesday, October 4th. KeyCorp reiterated a “hold” rating on shares of Halyard Health in a report on Tuesday, October 17th. Finally, BidaskClub upgraded shares of Halyard Health from a “hold” rating to a “buy” rating in a report on Saturday, August 19th. Three equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Halyard Health currently has an average rating of “Buy” and an average price target of $44.00.
TRADEMARK VIOLATION WARNING: “Halyard Health, Inc. (HYH) Position Lessened by Strs Ohio” was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/11/06/halyard-health-inc-hyh-position-lessened-by-strs-ohio.html.
Halyard Health, Inc. (NYSE:HYH) opened at $47.33 on Monday. Halyard Health, Inc. has a 1-year low of $32.60 and a 1-year high of $50.99. The firm has a market cap of $2,216.77, a P/E ratio of 22.65, a P/E/G ratio of 2.56 and a beta of 1.69. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.13 and a quick ratio of 1.19.
Halyard Health (NYSE:HYH) last announced its quarterly earnings data on Wednesday, November 1st. The medical instruments supplier reported $0.60 earnings per share for the quarter, topping analysts’ consensus estimates of $0.47 by $0.13. Halyard Health had a net margin of 3.52% and a return on equity of 8.65%. The company had revenue of $401.40 million during the quarter, compared to analyst estimates of $394.54 million. During the same period in the previous year, the business earned $0.48 EPS. The firm’s revenue for the quarter was up 1.0% on a year-over-year basis. analysts anticipate that Halyard Health, Inc. will post 2.08 earnings per share for the current year.
About Halyard Health
Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.
Want to see what other hedge funds are holding HYH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Halyard Health, Inc. (NYSE:HYH).
Receive News & Stock Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related stocks with our FREE daily email newsletter.